Sukanya Panja

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 228 citations · Full text

Ezh2 Inhibition, Dsrna–sting–interferon Stress, Medicine +6

A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance

Juan Martín Arriaga, Sukanya Panja, Mohammed Alshalalfa et al. · Nature Cancer · 2020 · 78 citations · Full text

Urology, Oncology, Ras Co-activation Signature +9

NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation

Alexandros Papachristodoulou, Antonio Rodríguez-Calero, Sukanya Panja et al. · Cancer Discovery · 2021 · 42 citations · Full text

Cooperation of loss of <i>NKX3.1</i> and inflammation in prostate cancer initiation

Clémentine Le Magnen, Renu K. Virk, Aditya Dutta et al. · Disease Models & Mechanisms · 2018 · 38 citations · Full text

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition

Aditya Dutta, Sukanya Panja, Renu K. Virk et al. · European Urology · 2017 · 22 citations · Full text

5α-Reductase Inhibition, Medicine, Nkx3.1 Expression +7